tirzepatide week 4 weight loss percent In adults with obesity but not diabetes, leads to significantly greater than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Semaglutide vs Tirzepatide: Which GLP-1

This study strengthens the argument for long-term, guideline-consistent obesity treatment and proactive conversations with patients about expectations, durability, and the chronic nature of care

Regulatory navigation support: JaYoo Biotech maintains active dossier tracking for SAG in major markets and provides regulatory status documentation (COA, stability data, manufacturing flow charts) to support our clients product registrations and novel food applications

You can book online or contact our Flatiron clinic directly by phone or text

Personalized Treatment Plan: Development of a customized weight loss plan that may include medications like semaglutide, dietary recommendations, and exercise guidelines